2009 Annual Meeting | Resident Basic Science II: Neurometabolic Disorders

Date Saturday 04/25/09

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Marc C. Patterson, MD, FRACP, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the basic metabolic pathways that influence nervous system function and the pathophysiology of diseases of these pathways, and will be able to use this information to formulate a rational approach to the diagnosis and management of neurometabolic diseases.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Introductory

Recommended Audience Fellow, Resident

Event Timeline
02:15 PM - 03:00 PM		Small Molecule Diseases I: Urea Cycle, Fatty Acid Oxidation, Respiratory Chain Deborah L. Renaud, MD
03:00 PM - 03:45 PM		Small Molecule Diseases II: Amino and Organic Acids, Neurotransmitters PHILLIP L. PEARL, MD, FAAN
03:45 PM - 04:00 PM		Break
04:00 PM - 04:15 PM		Questions and Answers PHILLIP L. PEARL, MD, FAAN, Deborah L. Renaud, MD
04:15 PM - 05:00 PM		Large Molecule Diseases I: Lysosomes Marc C. Patterson, MD, FRACP, FAAN
05:00 PM - 05:45 PM		Large Molecule Diseases II: Peroxisomes Lawrence R. Charnas, MD
05:45 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
PHILLIP L. PEARL, MD, FAAN	Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Marc C. Patterson, MD, FRACP, FAAN	Dr. Patterson has received personal compensation for serving as an employee of IntraBio. The institution of Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme /KemPharm/Zevra. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azafaros. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IntraBio. Dr. Patterson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. Dr. Patterson has stock in IntraBio. The institution of Dr. Patterson has received research support from Glycomine. The institution of Dr. Patterson has received research support from Orphazyme /KemPharm/Zevra. The institution of Dr. Patterson has received research support from Idorsia. The institution of Dr. Patterson has received research support from Shire-Takeda. Dr. Patterson has received publishing royalties from a publication relating to health care. Dr. Patterson has received publishing royalties from a publication relating to health care.
Lawrence R. Charnas, MD	No disclosure on file
Deborah L. Renaud, MD	No disclosure on file

��ɫ��

��ɫ��